EMA Authorised: Copalia (valsartan;amlodipine (as amlodipine besilate)) — Novartis Europharm Limited

View source ↗

Summary

The European Medicines Agency authorised Copalia, a fixed-dose combination of valsartan and amlodipine, for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• Copalia (Valsartan; Amlodipine)
• VALSARTAN (Valsartan)

Snippet

Status: Authorised. Therapeutic area: Hypertension. MAH: Novartis Europharm Limited. Decision date: 19/11/2025